Sweden: Axelsson decides to retire from CEO position at Vitrolife

Thomas Axelsson, CEO of Vitrolife, a provider of medical devices and genetic services, has decided to retire from his role. Despite his plans to leave the position, he will remain in place until the recruitment process for a new CEO has been concluded. The search for his replacement begins immediately and will be led by…

You must be a HMI Subscriber to view this content.

Subscribe Now »